FDA Application
-
NDC Search Results on Active Ingredient: aspirin
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
ASPIRIN | 70677-0092-1 | Strategic Sourcing Services LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 62011-0463-1 | Strategic Sourcing Services LLC | ANDA075794 | HUMAN OTC DRUG | ANDA |
ASPIRIN | 70677-0163-2 | Strategic Sourcing Services LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
ASPIRIN | 70677-0132-2 | Strategic Sourcing Services, LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN | 70677-0132-1 | Strategic Sourcing Services, LLC | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN | 70692-161-65 | Strive Pharmaceuticals Inc | part343 | HUMAN OTC DRUG | OTC monograph not final |
ASPIRIN | 70692-161-31 | Strive Pharmaceuticals Inc | part343 | HUMAN OTC DRUG | OTC monograph not final |
ASPIRIN | 70692-161-11 | Strive Pharmaceuticals Inc | part343 | HUMAN OTC DRUG | OTC monograph not final |
ASPIRIN | 70692-161-50 | Strive Pharmaceuticals Inc | part343 | HUMAN OTC DRUG | OTC monograph not final |
ASPIRIN | 70692-126-01 | Strive Pharmaceuticals Inc. | part343 | HUMAN OTC DRUG | OTC monograph not final |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 70692-142-31 | Strive Pharmaceuticals Inc. | part343 | HUMAN OTC DRUG | OTC monograph not final |
ASPIRIN; CAFFEINE; ACETAMINOPHEN | 70692-132-20 | Strive Pharmaceuticals Inc. | part343 | HUMAN OTC DRUG | OTC monograph not final |
ASPIRIN | 70692-158-01 | Strive Pharmaceuticals Inc. | part343 | HUMAN OTC DRUG | OTC monograph not final |
DIPYRIDAMOLE; ASPIRIN | 47335-927-83 | Sun Pharmaceutical Industries, Inc. | ANDA208572 | HUMAN PRESCRIPTION DRUG | ANDA |
DIPYRIDAMOLE; ASPIRIN | 47335-927-86 | Sun Pharmaceutical Industries, Inc. | ANDA208572 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; ASPIRIN; DIPHENHYDRAMINE CITRATE | 49467-230-10 | Sunascen Therapeutics LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
ASPIRIN | 11534-155-11 | Sunrise Pharmaceutical Inc | part343 | HUMAN OTC DRUG | OTC monograph final |
ASPIRIN | 11534-073-11 | Sunrise Pharmaceutical Inc | part343 | HUMAN OTC DRUG | OTC monograph final |
ASPIRIN | 11534-073-05 | Sunrise Pharmaceutical Inc | part343 | HUMAN OTC DRUG | OTC monograph final |
ASPIRIN; SODIUM BICARBONATE; ANHYDROUS CITRIC ACID | 41163-421-68 | Supervalu Inc. | part343 | HUMAN OTC DRUG | OTC monograph final |
ASPIRIN; PHENYLEPHRINE BITARTRATE; CHLORPHENIRAMINE MALEATE | 41163-768-20 | Supervalu Inc. | part341 | HUMAN OTC DRUG | OTC monograph final |
NITROGLYCERIN; LEAD; ISOPROPYL PALMITATE; KEROSENE; PHYTOLACCA AMERICANA ROOT; LACTIC ACID, DL-; ESTRONE; PHENYLBUTAZONE; SORBITOL; CORTISONE ACETATE; STRYCHNOS NUX-VOMICA SEED; TARAXACUM OFFICINALE; PETROLATUM; PHOSPHORUS; BORIC ACID; INSULIN PORK; GLYCERIN; BENZYL ALCOHOL; SUS SCROFA THYROID; XYLITOL; STEARYL ALCOHOL; POTASSIUM SORBATE; RESORCINOL; SALICYLIC ACID; EUGENOL; BENZOIC ACID; NITRIC ACID; ARSENIC TRIOXIDE; ASPIRIN; LITHIUM CARBONATE; CHLORINE; ACETIC ACID; PHOSPHORIC ACID; CORTICOTROPIN | 71781-0003-1 | Supplement Clinic, LLC. | HUMAN OTC DRUG | unapproved homeopathic | |
ASPIRIN | 11673-378-90 | Target Corporation | part343 | HUMAN OTC DRUG | OTC monograph not final |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 11673-433-12 | Target Corporation | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN | 11673-416-90 | Target Corporation | part343 | HUMAN OTC DRUG | OTC monograph not final |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 11673-686-80 | TARGET Corporation | part343 | HUMAN OTC DRUG | OTC monograph not final |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 11673-070-72 | TARGET CORPORATION | part343 | HUMAN OTC DRUG | OTC monograph not final |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 11673-070-01 | TARGET CORPORATION | part343 | HUMAN OTC DRUG | OTC monograph not final |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 11673-686-20 | TARGET Corporation | part343 | HUMAN OTC DRUG | OTC monograph not final |
ASPIRIN | 11673-493-19 | TARGET CORPORATION | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
-